Generics 2

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Balsalazide manufacturers

2 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

2 products found

balsalazide

Capsules 750 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20801
This pharmaceutical manufacturer specializes in producing a wide range of medications across various dosage forms, including tablets, capsules, injections, and syrups. Their focus is on delivering high-quality formulations for human health, evident in their commitment to using state-of-the-art technology and machinery. The company exports its products to several key regions globally, such as Africa, the CIS countries, Central and Latin America, Southeast Asia, and the Pacific. While they haven't specified particular therapy areas, their mission statement emphasizes a dedication to becoming a dominant player in both domestic and international markets. They prioritize maintaining the highest quality standards through rigorous quality control measures and emphasize safe, stable packaging for all products.

Manufacturer usually replies in 11 days

Want to see all 2 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Balsalazide Manufacturers

Balsalazide is an anti-inflammatory drug belongs to a class of drugs called aminosalicylates. This drug is used in the treatment of inflammatory bowel disease like ulcerative colitis. It reduces the symptoms of ulcerative colitis such as diarrhea, stomach pain and rectal bleeding. Balsalazide is advised as a prescription product and generic prescription product. Before using this medication, the risk of taking the drug must be weighed against the benefits it provides. It is always recommended to consult a physician before taking Balsalazide as this medication may interact with other drugs and health problems. Balsalazide is marketed by manufacturers under the brand name of Colazal and Giazo. This drug is available only with the doctor’s prescription and is available in the dosage form of Tablet (film coated) and Capsule which is taken by mouth with or without food. Balsalazide is available in dosage strength of 750 mg and 1.1 g The Colazal brand of Balsalazide is used to treat mild to moderate active ulcerative colitis in adults and patients 5 years of age and older and the Giazo brand of Balsalazide is used to treat mild and moderate ulcerative colitis in patients 18 years of age and older . The recommended initial dose in adults for active ulcerative colitis is three 750 mg Balsalazide capsules three times a day i.e. (6.75 g per day) for up to 8 weeks or three 1.1 g tablets twice a day i.e. (6.6 g per day) for up to 8 weeks. The usual dose in pediatrics, aged 5 - 17 years for the treatment of active ulcerative colitis is either three 750 mg Balsalazide capsules three times a day i.e. (6.75 g per day) for up to 8 weeks or one 750 mg Balsalazide capsule 3 times a day (2.25 g per day) for up to 8 weeks. Balsalazide is recommended to store at 20° C to 25° C (68° F - 77° F), with excursion permitted between 15° C to 30° C (59° F - 86° F).

Wholesale Price of Balsalazide

The wholesale price for Balsalazide oral capsule 750 mg is around $ 31 for a supply of 30 tablets with per unit cost available at $ 1.03 For a set of 280 Balsalazide oral capsule 750 mg it costs approximately between $ 151.56 - $ 210.31 with a per unit price available at as low as $ 0.54 – 0.75

Balsalazide - Mechanism of Action

Balsalazide is a prodrug that had little or no pharmacologic activity until it is enzymatically divided in the colon to produce mesalamine (5-aminosalicylic acid), an anti-inflammatory drug indicated for the treatment of mild to moderate active ulcerative colitis. Balsalazide is released intact in to the colon, where it is divided by bacterial azoreduction to release mesalamine, which is therapeutic active portion of the molecule. This 5-aminosalicylic acid exerts its anti-inflammatory effects locally in the gastrointestinal tract by blocking production of arachidonic acid metabolites in the colon through both the inhibition of cyclooxygenase and lipoxygenase.

Finding Balsalazide Manufacturers and Suppliers

Finding a faithful partner in our business is one of the massive tests and to defeat that challenge and to make one’s work and life easy in finding the credible manufacturer and supplier of Balsalazide, one can visit the Pipelinepharma website which helps you in finding the dependable manufacturers and suppliers of Balsalazide. Pipelinepharma, which is a business-to-business (B2B) licensing marketplace for pharmaceutical products, quickly connects proprietor with the consumers for the business development. You can filter the product names in user familiar and unified search engine by its country, category, therapeutic area, forms, dossier and its status, regulatory filings, approvals, and more.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible